Lorelei Integrated Therapeutics, Inc. — Form D

Lorelei Integrated Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-08. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2022-07-08
• Form: D
• Accession: 0001937199-22-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $1.0M
• Remaining: $965K
• Investors: 7
• Date of first sale: 2022-06-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-451575

Issuer

• Name: Lorelei Integrated Therapeutics, Inc.
• CIK: 0001937199
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 1923 WASHINGTON AVENUE, HOUSTON, TX, 77007
• Phone: 8328658431

Officers, directors & promoters (2)

More

• CIK 1937199 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search